New radiation combo aims to shrink oral tumors before surgery
NCT ID NCT07335380
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new type of radiation (lattice radiotherapy) given with chemotherapy and immunotherapy before surgery for oral cavity cancer. About 30 adults with advanced but removable tumors will receive different radiation doses to find the safest level. The goal is to see if this combination can shrink tumors more effectively before surgery, while monitoring side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL CAVITY SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aiming to spare the neck: could smarter radiation cut side effects in oral cancer?
- Less neck surgery may be just as effective for oral cancer with one affected node
- Bee product may boost health in oral cancer survivors
- Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients
- New pastille could change head and neck cancer treatment
- Glowing dots could help surgeons spot hidden cancer during surgery